Vitrolife
154.5
SEK
-0.45 %
Less than 1K followers
VITR
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
-0.45%
-1.97%
-21.57%
-28.14%
-31.27%
-16.35%
-42.99%
-19.49%
+2,417.52%
Vitrolife is a global provider of solutions in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics in enhancing their practice as well as the outcome of a patient’s fertility treatment. Vitrolife´s products and services are available globally, and the company is headquartered in Gothenburg, Sweden.
Read moreMarket cap
20.93B SEK
Turnover
1.75M SEK
Revenue
3.61B
EBIT %
21.7 %
P/E
40.77
Dividend yield-%
0.71 %
Financial calendar
17/7
2025
Interim report Q2'25
23/10
2025
Interim report Q3'25
29/1
2026
Annual report '25
All
Press releases
3rd party
ShowingAll content types
Vitrolife AB (publ) går in som huvudinvesterare i AutoIVF
Kommuniké från årsstämma i Vitrolife AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools